Results 11 to 20 of about 38,782 (264)
Effect of alveolar volume on the interpretation of single breath DlCO
Single-breath carbon monoxide diffusing capacity in the whole lung (DLCO) and per unit alveolar volume (DLCO/VA), as expressed in percentage of normal values, gave discordant results when VA of the patients was abnormal. It was hypothesized that normal reference values were inappropriate to interpret data collected in such patients.
Albert Frans+4 more
semanticscholar +5 more sources
Pulmonary vascular volume is associated with DLCO and fibrotic score in idiopathic pulmonary fibrosis: an observational study [PDF]
Background Idiopathic pulmonary fibrosis (IPF) is a disease that primarily occurs in elderly individuals. However, it is difficult to diagnose and has a complex disease course.
Wen-Jui Wu+3 more
openalex +2 more sources
Background Endoscopic lung volume reduction (ELVR) with valves has been suggested to be the key strategy for patients with severe emphysema and concomitant low diffusing capacity of the lung for carbon monoxide (DLCO).
Pavlina Lenga+15 more
doaj +2 more sources
Different KCO and VA combinations exist for the same DLCO value in patients with diffuse parenchymal lung diseases [PDF]
BackgroundDLCO is the product of the CO transfer coefficient (KCO) by the “accessible” alveolar volume (VA). In theory, the same DLCO may result from various combinations of KCO and VA values, each of which reflect different injury sites and mechanisms ...
Jean Pastré+6 more
openalex +2 more sources
Endobronchial Valve Treatment in Emphysema Patients with a Very Low DLCO [PDF]
<b><i>Background:</i></b> For selected patients with severe emphysema, bronchoscopic lung volume reduction with endobronchial valves (EBV) is recognized as an additional treatment option. In most trials investigating EBV treatment, patients with a very low diffusing capacity (DLCO) were excluded from participation.
Marlies van Dijk+5 more
openaire +4 more sources
Impaired diffusing capacity of the lung for carbon monoxide (DLCO) was frequently observed in systemic sclerosis (SSc) patients, generally related to the presence of interstitial lung disease (ILD) and/or pulmonary arterial hypertension (PAH).
Michele Colaci+7 more
openalex +3 more sources
Background and objectiveCurrently there is paucity of evidence in the literature in relation to normative values for diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) among Indigenous Australians. Hence, in this study we assessed
Timothy Howarth+5 more
doaj +2 more sources
Time-based understanding of DLCO and DLNO
Capture of CO and NO by blood requires molecules to travel by diffusion from alveolar gas to haemoglobin molecules inside RBCs and then to react. One can attach to these processes two times, a time for diffusion and a time for reaction. This reaction time is known from chemical kinetics and, therefore, constitutes a unique physical clock.
Bernard Sapoval, Min-Yeong Kang
openaire +4 more sources
Exercise pulmonary hypertension is an underappreciated form of physical limitation related to early pulmonary vascular disease. A low diffusing capacity of lungs for carbon monoxide (DLco) can be seen in patients with resting pulmonary hypertension as ...
Richard H. Zou+4 more
doaj +2 more sources
The prognostic value of DLCO and pulmonary blood flow in patients with pulmonary hypertension [PDF]
BackgroundCardiac output is a prognostic marker in patients with pulmonary hypertension. Pulmonary blood flow as a surrogate for cardiac output can be measured non‐invasively by inert gas rebreathing. We hypothesized that pulmonary blood flow can predict outcome in patients with pulmonary hypertension.MethodsFrom January 2009 to January 2012, we ...
Stadler, Stefan+2 more
openaire +5 more sources